The recent efforts in next-generation sequencing have revealed that Rho GTPases are mutated in a variety of cancers, and recurrent mutations in RAC1 and RHOA have been identified [3,127,128,129,130,131,132,133,134,135]. Here, RHOA is linked to cancer.